Aircraft Seat OEMs Explore Economy Cabin Improvements
Economy cabin seating trends are evolving toward greater comfort and enhanced IFE capabilities.
Source: aviationweek.com
📰 David Pook News
David Pook News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from David Pook. Real-time updates on events, politics, business and more.
My Life & Cars – David Pook, Vehicle dynamics engineer and founder of Life110
His tuned Alpine A110s have blown us away; here David Pook talks about his career highs at Jaguar Land Rover and his personal favourites among the cars that he’s owned
Source: evo.co.uk
Expensive cancer treatments set to become cheaper from October 1
Two cancer drugs are set to be added to the Pharmaceutical Benefits Scheme from October 1 allowing more pat...
Source: 9news.com.au
New prostate cancer treatment subsidy breaks seven-year PBS listing drought
For the first time in seven years, a prostate cancer therapy will be added to the Pharmaceutical Benefits Scheme (PBS), providing affordable treatment
David Pook Pharmaceutical Benefits Scheme Federal Government Associate Professor David Pook Medical Oncologist Cabrini Hospital
Source: miragenews.com
NBN News | PROSTATE CANCER TREATMENT TO BE PUT ON PBS
For the first time in seven years, a prostate cancer therapy will be added to the Pharmaceutical Benefits Scheme (PBS). From Monday, men with a high-risk form of the disease that no longer responds to traditional testosterone-lowering therapy - known medically as castration resistant prostate ca ... by Madison Scott | NBN News-News, Sport & Weather
David Pook Pharmaceutical Benefits Scheme Federal Government Associate Professor David Pook Medical Oncologist Cabrini Hospital
Source: nbnnews.com.au
ANZUP Mini ASM 2021: Trial Updates: Renal Cell Carcinoma
UNISON trial nivolumab followed by ipilimumab + nivolumab in advanced non-clear cell RCC (ANZUP 1602), KeyPAD trial denosumab and pembrolizumab in patients with clear cell RCC (ANZUP 1601), UNICAB trial non-clear cell RCC post immunotherapy patients treated with cabozantinib, RAMPART trial Renal Adjuvant
Source: urotoday.com